The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Interventional Cardiology Market Research Report 2024
Synopsis
Interventional Cardiology is a kind of devices which is used in the treatment of cardiology area. Interventional Cardiology include cardiology catheters, guidewires, balloon catheters, coronary stents, fractional flow reserve (FFR), intravascular ultrasound.
The global Interventional Cardiology market was valued at US$ 3157 million in 2023 and is anticipated to reach US$ 3839.1 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
Global Interventional Cardiology key players include Medtronic, Inc., Boston Scientific Corporation, Abbott Vascular, MINVASYS S.A.S.. BIOTRONIK SE and Co. KG, etc. Global top five players hold a share about 40%.
North America is the largest market, with a share about 45%, followed by Europe and China, having a total share about 35 percent.
In terms of product, the segment includes Cardiology Catheters, Guidewires, Balloon Catheters, Coronary Stents, Fractional Flow Reserve, Intravascular Ultrasound. And in terms of application, the application includes Hospitals, Clinics, etc.
This report aims to provide a comprehensive presentation of the global market for Interventional Cardiology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interventional Cardiology.
Report Scope
The Interventional Cardiology market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Interventional Cardiology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Interventional Cardiology manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic, Inc.
Boston Scientific Corporation
Abbott Vascular
MINVASYS S.A.S.
BIOTRONIK SE and Co. KG
Bard Peripheral Vascular，Inc
TERUMO CORPORATION
KANEKA
OrbusNeich Medical, BV
Cordis Cashel
Kimal Plc
Volcano Corporation
Siemens Medical Solutions USA, Inc
Lepu
MicroPort
Segment by Type
Cardiology Catheters
Guidewires
Balloon Catheters
Coronary Stents
Fractional Flow Reserve
Intravascular Ultrasound
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Interventional Cardiology manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Interventional Cardiology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Interventional Cardiology is a kind of devices which is used in the treatment of cardiology area. Interventional Cardiology include cardiology catheters, guidewires, balloon catheters, coronary stents, fractional flow reserve (FFR), intravascular ultrasound.
The global Interventional Cardiology market was valued at US$ 3157 million in 2023 and is anticipated to reach US$ 3839.1 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.
Global Interventional Cardiology key players include Medtronic, Inc., Boston Scientific Corporation, Abbott Vascular, MINVASYS S.A.S.. BIOTRONIK SE and Co. KG, etc. Global top five players hold a share about 40%.
North America is the largest market, with a share about 45%, followed by Europe and China, having a total share about 35 percent.
In terms of product, the segment includes Cardiology Catheters, Guidewires, Balloon Catheters, Coronary Stents, Fractional Flow Reserve, Intravascular Ultrasound. And in terms of application, the application includes Hospitals, Clinics, etc.
This report aims to provide a comprehensive presentation of the global market for Interventional Cardiology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interventional Cardiology.
Report Scope
The Interventional Cardiology market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Interventional Cardiology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Interventional Cardiology manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic, Inc.
Boston Scientific Corporation
Abbott Vascular
MINVASYS S.A.S.
BIOTRONIK SE and Co. KG
Bard Peripheral Vascular，Inc
TERUMO CORPORATION
KANEKA
OrbusNeich Medical, BV
Cordis Cashel
Kimal Plc
Volcano Corporation
Siemens Medical Solutions USA, Inc
Lepu
MicroPort
Segment by Type
Cardiology Catheters
Guidewires
Balloon Catheters
Coronary Stents
Fractional Flow Reserve
Intravascular Ultrasound
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Interventional Cardiology manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Interventional Cardiology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Interventional Cardiology Market Overview
1.1 Product Overview and Scope of Interventional Cardiology
1.2 Interventional Cardiology Segment by Type
1.2.1 Global Interventional Cardiology Market Value Comparison by Type (2024-2030)
1.2.2 Cardiology Catheters
1.2.3 Guidewires
1.2.4 Balloon Catheters
1.2.5 Coronary Stents
1.2.6 Fractional Flow Reserve
1.2.7 Intravascular Ultrasound
1.3 Interventional Cardiology Segment by Application
1.3.1 Global Interventional Cardiology Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Interventional Cardiology Market Size Estimates and Forecasts
1.4.1 Global Interventional Cardiology Revenue 2019-2030
1.4.2 Global Interventional Cardiology Sales 2019-2030
1.4.3 Global Interventional Cardiology Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Interventional Cardiology Market Competition by Manufacturers
2.1 Global Interventional Cardiology Sales Market Share by Manufacturers (2019-2024)
2.2 Global Interventional Cardiology Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Interventional Cardiology Average Price by Manufacturers (2019-2024)
2.4 Global Interventional Cardiology Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Interventional Cardiology, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Interventional Cardiology, Product Type & Application
2.7 Interventional Cardiology Market Competitive Situation and Trends
2.7.1 Interventional Cardiology Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Interventional Cardiology Players Market Share by Revenue
2.7.3 Global Interventional Cardiology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Interventional Cardiology Retrospective Market Scenario by Region
3.1 Global Interventional Cardiology Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Interventional Cardiology Global Interventional Cardiology Sales by Region: 2019-2030
3.2.1 Global Interventional Cardiology Sales by Region: 2019-2024
3.2.2 Global Interventional Cardiology Sales by Region: 2025-2030
3.3 Global Interventional Cardiology Global Interventional Cardiology Revenue by Region: 2019-2030
3.3.1 Global Interventional Cardiology Revenue by Region: 2019-2024
3.3.2 Global Interventional Cardiology Revenue by Region: 2025-2030
3.4 North America Interventional Cardiology Market Facts & Figures by Country
3.4.1 North America Interventional Cardiology Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Interventional Cardiology Sales by Country (2019-2030)
3.4.3 North America Interventional Cardiology Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Interventional Cardiology Market Facts & Figures by Country
3.5.1 Europe Interventional Cardiology Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Interventional Cardiology Sales by Country (2019-2030)
3.5.3 Europe Interventional Cardiology Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Interventional Cardiology Market Facts & Figures by Country
3.6.1 Asia Pacific Interventional Cardiology Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Interventional Cardiology Sales by Country (2019-2030)
3.6.3 Asia Pacific Interventional Cardiology Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Interventional Cardiology Market Facts & Figures by Country
3.7.1 Latin America Interventional Cardiology Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Interventional Cardiology Sales by Country (2019-2030)
3.7.3 Latin America Interventional Cardiology Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Interventional Cardiology Market Facts & Figures by Country
3.8.1 Middle East and Africa Interventional Cardiology Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Interventional Cardiology Sales by Country (2019-2030)
3.8.3 Middle East and Africa Interventional Cardiology Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Interventional Cardiology Sales by Type (2019-2030)
4.1.1 Global Interventional Cardiology Sales by Type (2019-2024)
4.1.2 Global Interventional Cardiology Sales by Type (2025-2030)
4.1.3 Global Interventional Cardiology Sales Market Share by Type (2019-2030)
4.2 Global Interventional Cardiology Revenue by Type (2019-2030)
4.2.1 Global Interventional Cardiology Revenue by Type (2019-2024)
4.2.2 Global Interventional Cardiology Revenue by Type (2025-2030)
4.2.3 Global Interventional Cardiology Revenue Market Share by Type (2019-2030)
4.3 Global Interventional Cardiology Price by Type (2019-2030)
5 Segment by Application
5.1 Global Interventional Cardiology Sales by Application (2019-2030)
5.1.1 Global Interventional Cardiology Sales by Application (2019-2024)
5.1.2 Global Interventional Cardiology Sales by Application (2025-2030)
5.1.3 Global Interventional Cardiology Sales Market Share by Application (2019-2030)
5.2 Global Interventional Cardiology Revenue by Application (2019-2030)
5.2.1 Global Interventional Cardiology Revenue by Application (2019-2024)
5.2.2 Global Interventional Cardiology Revenue by Application (2025-2030)
5.2.3 Global Interventional Cardiology Revenue Market Share by Application (2019-2030)
5.3 Global Interventional Cardiology Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Medtronic, Inc.
6.1.1 Medtronic, Inc. Corporation Information
6.1.2 Medtronic, Inc. Description and Business Overview
6.1.3 Medtronic, Inc. Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Medtronic, Inc. Interventional Cardiology Product Portfolio
6.1.5 Medtronic, Inc. Recent Developments/Updates
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Corporation Information
6.2.2 Boston Scientific Corporation Description and Business Overview
6.2.3 Boston Scientific Corporation Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boston Scientific Corporation Interventional Cardiology Product Portfolio
6.2.5 Boston Scientific Corporation Recent Developments/Updates
6.3 Abbott Vascular
6.3.1 Abbott Vascular Corporation Information
6.3.2 Abbott Vascular Description and Business Overview
6.3.3 Abbott Vascular Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Vascular Interventional Cardiology Product Portfolio
6.3.5 Abbott Vascular Recent Developments/Updates
6.4 MINVASYS S.A.S.
6.4.1 MINVASYS S.A.S. Corporation Information
6.4.2 MINVASYS S.A.S. Description and Business Overview
6.4.3 MINVASYS S.A.S. Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MINVASYS S.A.S. Interventional Cardiology Product Portfolio
6.4.5 MINVASYS S.A.S. Recent Developments/Updates
6.5 BIOTRONIK SE and Co. KG
6.5.1 BIOTRONIK SE and Co. KG Corporation Information
6.5.2 BIOTRONIK SE and Co. KG Description and Business Overview
6.5.3 BIOTRONIK SE and Co. KG Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
6.5.4 BIOTRONIK SE and Co. KG Interventional Cardiology Product Portfolio
6.5.5 BIOTRONIK SE and Co. KG Recent Developments/Updates
6.6 Bard Peripheral Vascular，Inc
6.6.1 Bard Peripheral Vascular，Inc Corporation Information
6.6.2 Bard Peripheral Vascular，Inc Description and Business Overview
6.6.3 Bard Peripheral Vascular，Inc Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bard Peripheral Vascular，Inc Interventional Cardiology Product Portfolio
6.6.5 Bard Peripheral Vascular，Inc Recent Developments/Updates
6.7 TERUMO CORPORATION
6.6.1 TERUMO CORPORATION Corporation Information
6.6.2 TERUMO CORPORATION Description and Business Overview
6.6.3 TERUMO CORPORATION Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
6.4.4 TERUMO CORPORATION Interventional Cardiology Product Portfolio
6.7.5 TERUMO CORPORATION Recent Developments/Updates
6.8 KANEKA
6.8.1 KANEKA Corporation Information
6.8.2 KANEKA Description and Business Overview
6.8.3 KANEKA Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
6.8.4 KANEKA Interventional Cardiology Product Portfolio
6.8.5 KANEKA Recent Developments/Updates
6.9 OrbusNeich Medical, BV
6.9.1 OrbusNeich Medical, BV Corporation Information
6.9.2 OrbusNeich Medical, BV Description and Business Overview
6.9.3 OrbusNeich Medical, BV Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
6.9.4 OrbusNeich Medical, BV Interventional Cardiology Product Portfolio
6.9.5 OrbusNeich Medical, BV Recent Developments/Updates
6.10 Cordis Cashel
6.10.1 Cordis Cashel Corporation Information
6.10.2 Cordis Cashel Description and Business Overview
6.10.3 Cordis Cashel Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Cordis Cashel Interventional Cardiology Product Portfolio
6.10.5 Cordis Cashel Recent Developments/Updates
6.11 Kimal Plc
6.11.1 Kimal Plc Corporation Information
6.11.2 Kimal Plc Interventional Cardiology Description and Business Overview
6.11.3 Kimal Plc Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Kimal Plc Interventional Cardiology Product Portfolio
6.11.5 Kimal Plc Recent Developments/Updates
6.12 Volcano Corporation
6.12.1 Volcano Corporation Corporation Information
6.12.2 Volcano Corporation Interventional Cardiology Description and Business Overview
6.12.3 Volcano Corporation Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Volcano Corporation Interventional Cardiology Product Portfolio
6.12.5 Volcano Corporation Recent Developments/Updates
6.13 Siemens Medical Solutions USA, Inc
6.13.1 Siemens Medical Solutions USA, Inc Corporation Information
6.13.2 Siemens Medical Solutions USA, Inc Interventional Cardiology Description and Business Overview
6.13.3 Siemens Medical Solutions USA, Inc Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Siemens Medical Solutions USA, Inc Interventional Cardiology Product Portfolio
6.13.5 Siemens Medical Solutions USA, Inc Recent Developments/Updates
6.14 Lepu
6.14.1 Lepu Corporation Information
6.14.2 Lepu Interventional Cardiology Description and Business Overview
6.14.3 Lepu Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Lepu Interventional Cardiology Product Portfolio
6.14.5 Lepu Recent Developments/Updates
6.15 MicroPort
6.15.1 MicroPort Corporation Information
6.15.2 MicroPort Interventional Cardiology Description and Business Overview
6.15.3 MicroPort Interventional Cardiology Sales, Revenue and Gross Margin (2019-2024)
6.15.4 MicroPort Interventional Cardiology Product Portfolio
6.15.5 MicroPort Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Interventional Cardiology Industry Chain Analysis
7.2 Interventional Cardiology Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Interventional Cardiology Production Mode & Process
7.4 Interventional Cardiology Sales and Marketing
7.4.1 Interventional Cardiology Sales Channels
7.4.2 Interventional Cardiology Distributors
7.5 Interventional Cardiology Customers
8 Interventional Cardiology Market Dynamics
8.1 Interventional Cardiology Industry Trends
8.2 Interventional Cardiology Market Drivers
8.3 Interventional Cardiology Market Challenges
8.4 Interventional Cardiology Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
